Event Presentation: Spoke at the India-Japan Meeting on the Nobel Turing Challenge
Yosuke Ozawa, CEO of Epistra Inc., presented at the India-Japan Nobel Turing Challenge Meeting (IJNTC2025), held in Tokyo from March 24 to 25, 2025.
The meeting was organized with the aim of “developing autonomous scientific discovery systems leveraging AI,” bringing together researchers and AI experts from around the world to discuss advances and applications of AI in scientific discovery.
The presentation, titled “Autonomous Optimization of Life Science Experiments,” introduced the use of black-box optimization techniques based on Bayesian optimization to address the complexity of life science experiments, with application examples including differentiation induction of iPS cells into retinal pigment epithelial cells. A new approach combining metabolomics data analysis and automated optimization technology was also presented.
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.